Skip to Main Content

Paper Details

<i>Helicobacter pylori</i>, Homologous-Recombination Genes, and Gastric Cancer.
N Engl J Med
50
2023
Cancer, Gastric Cancer, Homologous, Homologous-Recombination Genes, cancer, cancer-, cancer-predisposing genes, gastric, gastric cancer, homologous-recombination genes, patients, persons, predisposing genes
Author NameAffiliation
Yoichiro KamataniRIKEN Center for Integrative Medical Sciences, Aichi Cancer Center, Nagoya University Graduate School of Medicine, Aichi Cancer Center Research Institute (I.I.), Aichi Cancer Center Hospital (Y.N.), Okayama University Medical School, Institute of Microbial Chemistry, Microbial Chemistry Research Foundation (M. Hatakeyama), National Cancer Center Hospital (M. Hirata, Institute of Medical Science (M. Hirata, and the Laboratories of Complex Trait Genomics (Y. Kamatani) and Clinical Genome Sequencing (K. Matsuda), University of Tokyo, Kyoundo Hospital, Sasaki Foundation (K. Sugano), and the Research Center of Infection-Associated Cancer, Institute for Genetic Medicine, Hokkaido University, QIMR (Queensland Institute of Medical Research) Berghofer Medical Research Institute
Hidewaki NakagawaRIKEN Center for Integrative Medical Sciences, Aichi Cancer Center, Nagoya University Graduate School of Medicine, Aichi Cancer Center Research Institute (I.I.), Aichi Cancer Center Hospital (Y.N.), Okayama University Medical School, Institute of Microbial Chemistry, Microbial Chemistry Research Foundation (M. Hatakeyama), National Cancer Center Hospital (M. Hirata, Institute of Medical Science (M. Hirata, and the Laboratories of Complex Trait Genomics (Y. Kamatani) and Clinical Genome Sequencing (K. Matsuda), University of Tokyo, Kyoundo Hospital, Sasaki Foundation (K. Sugano), and the Research Center of Infection-Associated Cancer, Institute for Genetic Medicine, Hokkaido University, QIMR (Queensland Institute of Medical Research) Berghofer Medical Research Institute
Amanda B SpurdleRIKEN Center for Integrative Medical Sciences, Aichi Cancer Center, Nagoya University Graduate School of Medicine, Aichi Cancer Center Research Institute (I.I.), Aichi Cancer Center Hospital (Y.N.), Okayama University Medical School, Institute of Microbial Chemistry, Microbial Chemistry Research Foundation (M. Hatakeyama), National Cancer Center Hospital (M. Hirata, Institute of Medical Science (M. Hirata, and the Laboratories of Complex Trait Genomics (Y. Kamatani) and Clinical Genome Sequencing (K. Matsuda), University of Tokyo, Kyoundo Hospital, Sasaki Foundation (K. Sugano), and the Research Center of Infection-Associated Cancer, Institute for Genetic Medicine, Hokkaido University, QIMR (Queensland Institute of Medical Research) Berghofer Medical Research Institute
Amanda B SpurdleRIKEN Center for Integrative Medical Sciences, Aichi Cancer Center, Nagoya University Graduate School of Medicine, Aichi Cancer Center Research Institute (I.I.), Aichi Cancer Center Hospital (Y.N.), Okayama University Medical School, Institute of Microbial Chemistry, Microbial Chemistry Research Foundation (M. Hatakeyama), National Cancer Center Hospital (M. Hirata, Institute of Medical Science (M. Hirata, and the Laboratories of Complex Trait Genomics (Y. Kamatani) and Clinical Genome Sequencing (K. Matsuda), University of Tokyo, Kyoundo Hospital, Sasaki Foundation (K. Sugano), and the Research Center of Infection-Associated Cancer, Institute for Genetic Medicine, Hokkaido University, QIMR (Queensland Institute of Medical Research) Berghofer Medical Research Institute
  • 1 - 4

Datasets